Cellular immunity and Chlamydia genital infection: induction, recruitment, and effector mechanisms.
about
Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in miceDistinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions.Heat denatured enzymatically inactive recombinant chlamydial protease-like activity factor induces robust protective immunity against genital chlamydial challengeInduction of protective immunity against Chlamydia muridarum intravaginal infection with the chlamydial immunodominant antigen macrophage infectivity potentiator.Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis.A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin.Intranasal vaccination with Chlamydia pneumoniae induces cross-species immunity against genital Chlamydia muridarum challenge in mice.Efficacy of an immune modulator in experimental Chlamydia trachomatis infection of the female genital tract.Chlamydia muridarum infection associated host MicroRNAs in the murine genital tract and contribution to generation of host immune response.Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 alleleIntranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cellsIdentification of dendritic cell subsets responding to genital infection by Chlamydia muridarum.CXCL13 expression in Chlamydia trachomatis infection of the female reproductive tractInduction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach.Intramuscular Priming and Intranasal Boosting Induce Strong Genital Immunity Through Secretory IgA in Minipigs Infected with Chlamydia trachomatis.Modulation of cytokines and transcription factors (T-Bet and GATA3) in CD4 enriched cervical cells of Chlamydia trachomatis infected fertile and infertile women upon stimulation with chlamydial inclusion membrane proteins B and C.Enhanced fusion and virion incorporation for HIV-1 subtype C envelope glycoproteins with compact V1/V2 domainsChronic Infection of the Prostate by Chlamydia muridarum Is Accompanied by Local Inflammation and Pelvic Pain Development.In vivo whole animal body imaging reveals colonization of Chlamydia muridarum to the lower genital tract at early stages of infection.A multi-epitope vaccine based on Chlamydia trachomatis major outer membrane protein induces specific immunity in mice.Identification of human T cell targets recognized during Chlamydia trachomatis genital infection.Temporal cytokine gene expression patterns in subjects with trachoma identify distinct conjunctival responses associated with infection.Cytokine expression pattern in the genital tract of Chlamydia trachomatis positive infertile women - implication for T-cell responses.Non-Chlamydial Bacterial Infection and Progression of Conjunctival Scarring in Trachoma.
P2860
Q24813686-5FB27147-A037-4F0F-83E1-CFE9D3FA5ED5Q30794373-06065A5B-6013-4957-8B70-BCF9B7FFA03DQ33757531-8777EFB9-7B7A-4195-BF3E-5E70AABDB815Q34445366-5764D47D-596A-4913-AFEA-4169A4FFEEE3Q34607259-1D22B7D7-DF77-4F1E-96AF-F7C458BA5623Q34708547-82655F19-4278-435B-9DB8-5D79714F6D1FQ34760989-7189D7D8-922C-4A80-B127-559391D97FDBQ35056798-4A20B0ED-608F-4CC7-A597-AF24CFAA3E83Q35169667-A4032667-3817-4BA6-922C-0CA0D42B4AEBQ35220270-DAF0FC69-5577-4374-BD76-3936B413DE5FQ35689196-5A3643D2-1FCA-4B22-978F-F8868B35EEBDQ35828850-D12F8E64-B97C-490D-BBA4-AA58FAFE6FCFQ35832823-69943A6A-BC2C-40B9-92E4-F719FF88FE8DQ35869068-A2EDA2B7-2A9B-4744-8C3F-40E94D54271EQ36314065-15DC6A75-963E-4D7C-B5E3-4AF28F9F5EEAQ36373913-319C7BED-7C7F-4FEC-9647-A4686EC27CC8Q37331068-27568603-38B1-4B5D-90C1-3DF180BAD2C0Q37547162-109C222A-4861-457F-BBAB-510443C0E36FQ37835151-FBA66C0D-2678-4F05-9F7F-81B5F9435901Q37844533-3455CAA8-241D-439B-9CB6-08842A52BA17Q37844654-7DD5DE4D-7149-41AE-A62A-5C163904D635Q37858681-46317FE7-8DB1-4B5E-8D1D-21D6488487F1Q37863729-4614B746-225D-4C45-8594-2D9B1705AAE7Q37866607-27DCAF8D-7557-4A46-B828-18B8F47DA93CQ55325369-09D6A6E9-47C2-4D90-8F3D-637C4E2E0894
P2860
Cellular immunity and Chlamydia genital infection: induction, recruitment, and effector mechanisms.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cellular immunity and Chlamydi ...... ment, and effector mechanisms.
@ast
Cellular immunity and Chlamydi ...... ment, and effector mechanisms.
@en
type
label
Cellular immunity and Chlamydi ...... ment, and effector mechanisms.
@ast
Cellular immunity and Chlamydi ...... ment, and effector mechanisms.
@en
prefLabel
Cellular immunity and Chlamydi ...... ment, and effector mechanisms.
@ast
Cellular immunity and Chlamydi ...... ment, and effector mechanisms.
@en
P2860
P356
P1476
Cellular immunity and Chlamydi ...... ment, and effector mechanisms.
@en
P2093
Kathleen A Kelly
P2860
P356
10.1080/08830180305229
P577
2003-01-01T00:00:00Z